+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sirolimus Market by Product Type (Generic, Innovator), Formulation (Injectable, Oral Solution, Softgel Capsules), Application, Distribution Channel, End User, Route Of Administration - Global Forecast 2025-2030- Product Image
Sirolimus Market by Product Type (Generic, Innovator), Formulation (Injectable, Oral Solution, Softgel Capsules), Application, Distribution Channel, End User, Route Of Administration - Global Forecast 2025-2030- Product Image
Sale

Sirolimus Market by Product Type (Generic, Innovator), Formulation (Injectable, Oral Solution, Softgel Capsules), Application, Distribution Channel, End User, Route Of Administration - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082729
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sirolimus market is evolving rapidly as healthcare stakeholders leverage its expanding therapeutic potential and enhance delivery solutions across specialties. As regulatory dynamics shift and new clinical indications emerge, senior decision-makers require current, actionable intelligence to guide strategic decisions in a complex global environment.

Sirolimus Market Snapshot

In 2024, the Sirolimus market was valued at USD 530.49 million and is projected to reach USD 576.90 million in 2025, supported by a robust CAGR of 8.51%. This continued growth trajectory is set to push market value to USD 865.95 million by 2030. Expansion is driven by a shift from niche post-transplant usage to wider adoption in autoimmune and oncology therapy protocols. As biosimilar alternatives gain traction, and combination therapies solidify clinical relevance, market participants are tasked with re-evaluating positioning and operational agility to sustain competitiveness.

Scope & Segmentation of the Global Sirolimus Market

This research report delivers comprehensive coverage of the Sirolimus market, profiling current trends and segment performance:

  • Product Type: Innovator products and generic alternatives.
  • Formulation: Injectable, oral solution, softgel capsules, and tablets.
  • Application: Autoimmune disorders (psoriasis, rheumatoid arthritis), oncology, and transplantation (kidney, liver).
  • Distribution Channel: Hospital pharmacies, online platforms, retail pharmacies.
  • End User: Ambulatory surgical centers, clinics, hospitals.
  • Route of Administration: Intravenous and oral dosing approaches.
  • Geographies:
    • Americas—markets include United States, Canada, Mexico, Brazil, Argentina, and key U.S. states such as California and Texas.
    • Europe, Middle East & Africa—focus on Western Europe, Middle East, and Africa with diverse national landscapes from the United Kingdom and Germany to South Africa and Saudi Arabia.
    • Asia-Pacific—encompasses China, India, Japan, Australia, and other dynamic growth markets.
  • Leading Companies: Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Aurobindo Pharma Limited, Cadila Healthcare Limited, Accord Healthcare, Actiza Pharmaceutical Private Limited, Amneal Pharmaceuticals LLC, Apotex Inc.

Key Takeaways for Senior Decision-Makers

  • Strategic investment in novel drug delivery technologies supports extended lifecycle value and patient adherence across new indications.
  • Market penetration by generic manufacturers intensifies price-based competition but also advances broader patient access, especially in developing economies.
  • Collaborations for innovative formulations and risk-sharing agreements with payers can improve access and align stakeholder interests in outcome-driven healthcare environments.
  • Region-specific strategies remain crucial—regulatory complexity and reimbursement structures in different markets require tailored approaches for successful product launch or scale-up.
  • Digital health integration and advanced analytics streamline patient monitoring, pharmacovigilance, and adherence support, driving improved clinical and commercial performance.

Tariff Impact on Sirolimus Supply Chains and Pricing

Tariffs imposed in the United States in 2025 have increased raw material costs and disrupted supply chain reliability. Manufacturers are mitigating these effects by expanding local procurement networks and establishing regional warehousing hubs. These adaptations aim to maintain competitive pricing and ensure therapy availability, but ongoing engagement with regulatory and customs authorities remains key amid shifting geopolitical risks.

Methodology & Data Sources

This study combines primary research, including interviews with clinical and procurement stakeholders, and extensive analysis of secondary sources such as peer-reviewed publications and regulatory documents. Integrated data triangulation, expert-panel validation, and statistical modeling underpin robust market forecasts and actionable segmentation insights.

Why This Report Matters

  • Enables strategic resource allocation and portfolio management based on granular market segmentation and emerging therapeutic opportunities.
  • Equips business leaders with a validated, data-driven foundation to navigate competitive, regulatory, and geopolitical complexities affecting the Sirolimus market.

Conclusion

The Sirolimus market is undergoing significant transformation, demanding agile strategies from industry leaders. In-depth analysis of trends, technologies, and competitive moves offers a clear roadmap for sustainable growth and enhanced patient outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of sirolimus-coated stents in peripheral artery disease interventions
5.2. Increased research into topical sirolimus formulations for rare dermatological diseases
5.3. Market entry of biosimilar sirolimus products driving competitive pricing pressure globally
5.4. Advancements in nanoparticle-based sirolimus delivery systems to enhance bioavailability in oncology
5.5. Supply chain challenges and raw material shortages impacting global sirolimus production volumes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sirolimus Market, by Product Type
8.1. Introduction
8.2. Generic
8.3. Innovator
9. Sirolimus Market, by Formulation
9.1. Introduction
9.2. Injectable
9.3. Oral Solution
9.4. Softgel Capsules
9.5. Tablets
10. Sirolimus Market, by Application
10.1. Introduction
10.2. Autoimmune Disorders
10.2.1. Psoriasis
10.2.2. Rheumatoid Arthritis
10.3. Oncology
10.4. Transplantation
10.4.1. Kidney Transplantation
10.4.2. Liver Transplantation
11. Sirolimus Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Sirolimus Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Hospitals
13. Sirolimus Market, by Route Of Administration
13.1. Introduction
13.2. Intravenous
13.3. Oral
14. Americas Sirolimus Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Sirolimus Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Sirolimus Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Sandoz International GmbH
17.3.3. Teva Pharmaceutical Industries Ltd.
17.3.4. Viatris Inc.
17.3.5. Sun Pharmaceutical Industries Ltd.
17.3.6. Dr. Reddy's Laboratories Ltd.
17.3.7. Cipla Limited
17.3.8. Aurobindo Pharma Limited
17.3.9. Cadila Healthcare Limited
17.3.10. Accord Healthcare.
17.3.11. Actiza Pharmaceutical Private Limited.
17.3.12. Amneal Pharmaceuticals LLC.
17.3.13. Apotex Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SIROLIMUS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SIROLIMUS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SIROLIMUS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SIROLIMUS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SIROLIMUS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SIROLIMUS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SIROLIMUS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SIROLIMUS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SIROLIMUS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SIROLIMUS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SIROLIMUS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SIROLIMUS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SIROLIMUS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SIROLIMUS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. SIROLIMUS MARKET: RESEARCHAI
FIGURE 28. SIROLIMUS MARKET: RESEARCHSTATISTICS
FIGURE 29. SIROLIMUS MARKET: RESEARCHCONTACTS
FIGURE 30. SIROLIMUS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SIROLIMUS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SIROLIMUS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SIROLIMUS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SIROLIMUS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SIROLIMUS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SIROLIMUS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SIROLIMUS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SIROLIMUS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SIROLIMUS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SIROLIMUS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SIROLIMUS MARKET SIZE, BY INNOVATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SIROLIMUS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SIROLIMUS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SIROLIMUS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SIROLIMUS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SIROLIMUS MARKET SIZE, BY SOFTGEL CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SIROLIMUS MARKET SIZE, BY SOFTGEL CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SIROLIMUS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SIROLIMUS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SIROLIMUS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SIROLIMUS MARKET SIZE, BY PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SIROLIMUS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SIROLIMUS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SIROLIMUS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SIROLIMUS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SIROLIMUS MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SIROLIMUS MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SIROLIMUS MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SIROLIMUS MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SIROLIMUS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SIROLIMUS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SIROLIMUS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SIROLIMUS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SIROLIMUS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SIROLIMUS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SIROLIMUS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SIROLIMUS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SIROLIMUS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SIROLIMUS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SIROLIMUS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SIROLIMUS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SIROLIMUS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SIROLIMUS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SIROLIMUS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SIROLIMUS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SIROLIMUS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SIROLIMUS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SIROLIMUS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SIROLIMUS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 110. CANADA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 111. CANADA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 112. CANADA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 113. CANADA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SIROLIMUS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 210. GERMANY SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 211. GERMANY SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. FRANCE SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. FRANCE SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 226. FRANCE SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 227. FRANCE SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. ITALY SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. ITALY SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 256. ITALY SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 257. ITALY SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 258. ITALY SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 259. ITALY SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ITALY SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ITALY SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ITALY SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ITALY SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SPAIN SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. SPAIN SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 274. SPAIN SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 275. SPAIN SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SPAIN SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 329. DENMARK SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. DENMARK SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. DENMARK SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 332. DENMARK SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 333. DENMARK SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. DENMARK SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. DENMARK SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 336. DENMARK SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 337. DENMARK SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 338. DENMARK SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 339. DENMARK SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. DENMARK SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. DENMARK SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. DENMARK SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. DENMARK SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 344. DENMARK SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 353. NETHERLANDS SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 354. NETHERLANDS SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 355. NETHERLANDS SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. NETHERLANDS SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. NETHERLANDS SIROLIMUS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 358. NETHERLANDS SIROLIMUS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 359. NETHERLANDS SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 360. NETHERLANDS SIROLIMUS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 361. QATAR SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 362. QATAR SIROLIMUS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 363. QATAR SIROLIMUS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 364. QATAR SIROLIMUS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 365. QATAR SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 366. QATAR SIROLIMUS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 367. QATAR SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 368. QATAR SIROLIMUS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 369. QATAR SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 370. QATAR SIROLIMUS MARKET SIZE, BY TRANSPLANTATION, 2025-2030 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Aurobindo Pharma Limited
  • Cadila Healthcare Limited
  • Accord Healthcare.
  • Actiza Pharmaceutical Private Limited.
  • Amneal Pharmaceuticals LLC.
  • Apotex Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 576.9 Million
Forecasted Market Value ( USD ) by 2030 $ 865.95 Million
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Sirolimus Drugs Market by Application (Cardiovascular Disease, Dermatology, Oncology), Form (Injection, Oral Suspension, Tablet), Route of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Sirolimus Drugs Market by Application (Cardiovascular Disease, Dermatology, Oncology), Form (Injection, Oral Suspension, Tablet), Route of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Immunosuppressants API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Immunosuppressants API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Immunosuppressants Market Report 2025 - Product Image

Immunosuppressants Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Immunomodulator Market Report 2025 - Product Image

Immunomodulator Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Sirolimus Market

Sirolimus, also known as rapamycin, is an immunosuppressive drug used to prevent organ rejection in transplant patients. It works by inhibiting the activity of T-cells, which are responsible for attacking foreign bodies. Sirolimus is also used to treat certain types of cancer, such as lymphoma and Kaposi's sarcoma. It is often used in combination with other immunosuppressive drugs, such as cyclosporine and tacrolimus. Sirolimus is available in both oral and intravenous formulations. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. It is also associated with an increased risk of infection and certain types of cancer. The sirolimus market is highly competitive, with several major players. These include Pfizer, Novartis, Merck, and Astellas. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.